Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP955395.RAR4yMp-f-jSM3Jny9gqqA3spNpHARvffyQ8WwYz0rD6E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP955395.RAR4yMp-f-jSM3Jny9gqqA3spNpHARvffyQ8WwYz0rD6E130_assertion type Assertion NP955395.RAR4yMp-f-jSM3Jny9gqqA3spNpHARvffyQ8WwYz0rD6E130_head.
- NP955395.RAR4yMp-f-jSM3Jny9gqqA3spNpHARvffyQ8WwYz0rD6E130_assertion description "[Furthermore, analysis of leptin-treated breast tumors shows increased expression of Wnt1, pGSK3?, and vimentin along with higher nuclear accumulation of ?-catenin and reduced E-cadherin expression providing in vivo evidence for a previously unrecognized cross-talk between leptin and MTA1/Wnt signaling in epithelial-mesenchymal transition of breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP955395.RAR4yMp-f-jSM3Jny9gqqA3spNpHARvffyQ8WwYz0rD6E130_provenance.
- NP955395.RAR4yMp-f-jSM3Jny9gqqA3spNpHARvffyQ8WwYz0rD6E130_assertion evidence source_evidence_literature NP955395.RAR4yMp-f-jSM3Jny9gqqA3spNpHARvffyQ8WwYz0rD6E130_provenance.
- NP955395.RAR4yMp-f-jSM3Jny9gqqA3spNpHARvffyQ8WwYz0rD6E130_assertion SIO_000772 22270359 NP955395.RAR4yMp-f-jSM3Jny9gqqA3spNpHARvffyQ8WwYz0rD6E130_provenance.
- NP955395.RAR4yMp-f-jSM3Jny9gqqA3spNpHARvffyQ8WwYz0rD6E130_assertion wasDerivedFrom befree-2016 NP955395.RAR4yMp-f-jSM3Jny9gqqA3spNpHARvffyQ8WwYz0rD6E130_provenance.
- NP955395.RAR4yMp-f-jSM3Jny9gqqA3spNpHARvffyQ8WwYz0rD6E130_assertion wasGeneratedBy ECO_0000203 NP955395.RAR4yMp-f-jSM3Jny9gqqA3spNpHARvffyQ8WwYz0rD6E130_provenance.